Alcohol consumption is associated with excessive risk of multiple sclerosis
a meta-analysis observational study
Keywords:
Alcohol drinking, Multiple sclerosis, Meta-analysis [publication type], Psychoneuroimmunology, Demyelinating diseasesAbstract
BACKGROUND: There have been inconsistent results regarding the association between alcohol intake and susceptibility to multiple sclerosis. OBJECTIVE: To assess the potential role of alcohol intake regarding the risk of multiple sclerosis by using a meta-analytic approach. DESIGN AND SETTING: Observational meta-analysis study conducted in a hospital in China. METHODS: The electronic databases of PubMed, EMBASE and the Cochrane library were systematically searched for eligible studies from their inception up to January 2020. The summary odds ratio (OR) with 95% confidence interval (CI) was applied to assess the association between alcohol intake and multiple sclerosis, using a random-effects model. RESULTS: One prospective cohort study and eight case-control studies involving a total of 211,396 subjects and 10,407 cases of multiple sclerosis were selected for the final meta-analysis. From the pooled data, no significant association between alcohol intake and multiple sclerosis risk was found (OR: 0.94; 95% CI: 0.73-1.22; P = 0.668), and this conclusion was judged to be robust. Subgroup analysis found that intake of beer was associated with an increased risk of multiple sclerosis (OR: 1.58; 95% CI: 1.12-2.23; P = 0.010). CONCLUSION: This study found that beer intake could cause an excess risk of multiple sclerosis. Further large-scale prospective studies should be conducted to verify this conclusion.
Downloads
References
Koch MW, Metz LM, Agrawal SM, Yong VW. Environmental factors and their regulation of immunity in multiple sclerosis. J Neurol Sci. 2013;324(1-2):10-6. PMID: 23154080; https://doi.org/10.1016/j.jns.2012.10.021.
Murray TJ. Diagnosis and treatment of multiple sclerosis. BMJ. 2006;332(7540):525-7. PMID: 16513709; https://doi.org/10.1136/bmj.332.7540.525.
Multiple Sclerosis International Federation. Atlas of MS 2013: Mapping Multiple Sclerosis Around the World; 2013. Available from: http://www.msif.org/wp-content/uploads/2014/09/Atlas-of-MS.pdf Accessed in 2021 (Sep 16).
Coetzee T, Thompson A. When are we going to take modifiable risk factors more seriously in multiple sclerosis? Mult Scler. 2017;23(4):494-5. PMID: 28287364; https://doi.org/10.1177/1352458517694433.
Hempel S, Graham GD, Fu N, et al. A systematic review of modifiable risk factors in the progression of multiple sclerosis. Mult Scler. 2017;23(4):525-33. PMID: 28151053; https://doi.org/10.1177/1352458517690270.
Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci. 2008;31:247-69. PMID: 18558855; https://doi.org/10.1146/annurev.neuro.30.051606.094313.
Mahad DH, Trapp BD, Lassmann H. Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol. 2015;14(2):183-93. PMID: 25772897; https://doi.org/10.1016/s1474-4422(14)70256-x.
Heidker RM, Emerson MR, LeVine SM. Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis. Neural Regen Res. 2017;12(8):1262-7. PMID: 28966637; https://doi.org/10.4103/1673-5374.213542.
Jelinek GA, De Livera AM, Marck CH, et al. Associations of Lifestyle, Medication, and Socio-Demographic Factors with Disability in People with Multiple Sclerosis: An International Cross-Sectional Study. PLoS One. 2016;11(8):e0161701. PMID: 27560626; https://doi.org/10.1371/journal.pone.0161701.
Paz-Ballesteros WC, Monterrubio-Flores EA, de Jesus Flores-Rivera J, Corona-Vazquez T, Hernandez-Giron C. Cigarette Smoking, Alcohol Consumption and Overweight in Multiple Sclerosis: Disability Progression. Arch Med Res. 2017;48(1):113-20. PMID: 28577864; https://doi.org/10.1016/j.arcmed.2017.03.002.
Degelman ML, Herman KM. Smoking and multiple sclerosis: A systematic review and meta-analysis using the Bradford Hill criteria for causation. Mult Scler Relat Disord. 2017;17:207-16. PMID: 29055459; https://doi.org/10.1016/j.msard.2017.07.020.
Costenbader KH, Gay S, Alarcon-Riquelme ME, Iaccarino L, Doria A. Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases? Autoimmun Rev. 2012;11(8):604-9. PMID: 22041580; https://doi.org/10.1016/j.autrev.2011.10.022.
Hedström AK, Hillert J, Olsson T, Alfredsson L. Alcohol as a modifiable lifestyle factor affecting multiple sclerosis risk. JAMA Neurol. 2014;71(3):300-5. PMID: 24395432; https://doi.org/10.1001/jamaneurol.2013.5858.
Massa J, O’Reilly EJ, Munger KL, Ascherio A. Caffeine and alcohol intakes have no association with risk of multiple sclerosis. Mult Scler. 2013; 19(1):53-8. PMID: 22641303; https://doi.org/10.1177/1352458512448108.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. PMID: 19621072; https://doi.org/10.1371/journal.pmed.1000097.
Wells G, Shea B, O’Connell D. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa (ON): Ottawa Hospital Research Institute 2009. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm Accessed in 2022 (Mar 22).
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-88. PMID: 3802833; https://doi.org/10.1016/0197-2456(86)90046-2.
Ades AE, Lu G, Higgins JP. The interpretation of random-effects meta-analysis in decision models. Med Decis Making. 2005;25(6):646-54. PMID: 16282215; https://doi.org/10.1177/0272989x05282643.
Deeks JJ HJ, Altman DG. Analysing Data and Undertaking Meta-Analyses. In: Higgins J GS, editor. Cochrane Handbook for Systematic Reviews of Interventions. UK: Oxford; 2008. p. 243-96.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-60. PMID: 12958120; https://doi.org/10.1136/bmj.327.7414.557.
Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Technical Bulletin. 1999;8(47). Available from: https://ideas.repec.org/a/tsj/stbull/y1999v8i47sbe26.html Accessed in 2021 (Sep 20).
Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ. 2003;326(7382):219. PMID: 12543843; https://doi.org/10.1136/bmj.326.7382.219.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-34. PMID: 9310563; https://doi.org/10.1136/bmj.315.7109.629.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088-101. PMID: 7786990.
Brosseau L, Philippe P, Methot G, Duquette P, Haraoui B. Drug abuse as a risk factor of multiple sclerosis: case-control analysis and a study of heterogeneity. Neuroepidemiology. 1993;12(1):6-14. PMID: 8327025; https://doi.org/10.1159/000110294.
Ghadirian P, Jain M, Ducic S, Shatenstein B, Morisset R. Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada. Int J Epidemiol. 1998;27(5):845-52. PMID: 9839742; https://doi.org/10.1093/ije/27.5.845.
Pekmezovic T, Drulovic J, Milenkovic M, et al. Lifestyle factors and multiple sclerosis: A case-control study in Belgrade. Neuroepidemiology. 2006;27(4):212-6. PMID: 17095875; https://doi.org/10.1159/000096853.
Kotzamani D, Panou T, Mastorodemos V, et al. Rising incidence of multiple sclerosis in females associated with urbanization. Neurology. 2012;78(22):1728-35. PMID: 22592376; https://doi.org/10.1212/WNL.0b013e31825830a9.
Hawkes CH, Boniface D. Risk associated behavior in premorbid multiple sclerosis: A case-control study. Mult Scler Relat Disord. 2014;3(1):40-7. PMID: 25877972; https://doi.org/10.1016/j.msard.2013.05.002.
Abdollahpour I, Nedjat S, Mansournia MA, Sahraian MA, van der Mei I. Lifestyle factors and multiple sclerosis: A population-based incident case-control study. Mult Scler Relat Disord. 2018;22:128-33. PMID: 29677591; https://doi.org/10.1016/j.msard.2018.03.022.
Andersen C, Søndergaard HB, Bang Oturai D, et al. Alcohol consumption in adolescence is associated with a lower risk of multiple sclerosis in a Danish cohort. Mult Scler. 2019; 25(12):1572-9. PMID: 30124094; https://doi.org/10.1177/1352458518795418.
Zhu T, Ye X, Zhang T, et al. Association between alcohol consumption and multiple sclerosis: a meta-analysis of observational studies. Neurol Sci. 2015;36(9):1543-50. PMID: 26160450; https://doi.org/10.1007/s10072-015-2326-7.
Goral J, Karavitis J, Kovacs EJ. Exposure-dependent effects of ethanol on the innate immune system. Alcohol. 2008;42(4):237-47. PMID: 18411007; https://doi.org/10.1016/j.alcohol.2008.02.003.
Mandrekar P, Catalano D, White B, Szabo G. Moderate alcohol intake in humans attenuates monocyte inflammatory responses: inhibition of nuclear regulatory factor kappa B and induction of interleukin 10. Alcohol Clin Exp Res. 2006;30(1):135-9. PMID: 16433741; https://doi.org/10.1111/j.1530-0277.2006.00012.x.
